Two Sigma Investments, LP Rigel Pharmaceuticals Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $55,846 - $78,284	49,863 Added 48.33%	153,031 $226,000
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.56 $119,283 - $258,448	-165,672 Reduced 61.62%	103,168 $149,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $1.59 Million - $2.07 Million	-1,487,234 Reduced 84.69%	268,840 $290,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $536,452 - $871,734	-478,975 Reduced 21.43%	1,756,074 $2.27 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $840,413 - $1.34 Million	672,331 Added 43.02%	2,235,049 $2.95 Million
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $20,004 - $355,298	29,857 Added 1.95%	1,562,718 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $1 Million - $11.1 Million	911,298 Added 146.61%	1,532,861 $1.81 Million
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $416,447 - $1.98 Million	621,563 New	621,563 $702,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $815,936 - $1.23 Million	-345,736 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $539,724 - $693,931	-154,207 Reduced 30.84%	345,736 $1.26 Million
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $2.44 Million - $3.59 Million	-790,844 Reduced 61.27%	499,943 $2.17 Million
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $4.32 Million - $6.36 Million	1,290,787 New	1,290,787 $4.41 Million
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $1.38 Million - $3.2 Million	-774,529 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $392,909 - $571,250	278,659 Added 56.2%	774,529 $1.42 Million
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $1.02 Million - $2.41 Million	-803,791 Reduced 61.85%	495,870 $774,000
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $224,212 - $340,523	140,133 Added 12.09%	1,299,661 $2.78 Million
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $162,113 - $260,574	-99,456 Reduced 7.9%	1,159,528 $2.17 Million
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $825,281 - $1.07 Million	-408,555 Reduced 24.5%	1,258,984 $3.29 Million
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $1.85 Million - $2.44 Million	922,510 Added 123.82%	1,667,539 $4.29 Million
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $274,761 - $443,845	132,097 Added 21.55%	745,029 $1.71 Million
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $122,769 - $169,516	-47,219 Reduced 7.15%	612,932 $1.97 Million
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $1.49 Million - $2.16 Million	526,511 Added 393.98%	660,151 $1.87 Million
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $365,062 - $468,187	-103,125 Reduced 43.56%	133,640 $473,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $718,390 - $956,371	222,412 Added 1549.59%	236,765 $919,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $31,289 - $36,887	14,353	14,353 $36,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account